Räikkönen K, Matthews KA, Kuller LH: Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care 30:872–877, 2007
Table 1 in the above-listed article inaccurately reported several of the clinical criteria for the metabolic syndrome. The analyses reported in the article were not based on the inaccurate values for Table 1 but were based on the correct criteria. All reported results, therefore, are correct. The correct table appears below.
Clinical criteria for the metabolic syndrome
Components . | WHO: fasting glucose above cutoff or taking medication for diabetes in combination with any two of the listed components . | ATP III: any three of the listed components . | IDF: waist circumference above cutoff in combination with any two of the listed components . |
---|---|---|---|
Fasting glucose | 1) ≥110 mg/dl* | 1) ≥100 mg/dl* | 1) ≥100 mg/dl* |
Triglycerides | 2) ≥150 mg/dl | 2) ≥150 mg/dl* | 2) >150 mg/dl* |
HDL cholesterol | 3) <39 mg/dl | 3) <50 mg/dl* | 3) <50 mg/dl* |
Obesity | 4) BMI >30 kg/m2 or waist-to-hip ratio >0.85 | 4) Waist circumference ≥88 cm | 4) Waist circumference ≥80 cm† |
Blood pressure | 5) SBP ≥140 mmHg and/or DBP ≥90 mmHg* | 5) SBP ≥130 mmHg and/or DBP ≥85 mmHg* | 5) SBP ≥130 mmHg and/or DBP ≥85 mmHg* |
Components . | WHO: fasting glucose above cutoff or taking medication for diabetes in combination with any two of the listed components . | ATP III: any three of the listed components . | IDF: waist circumference above cutoff in combination with any two of the listed components . |
---|---|---|---|
Fasting glucose | 1) ≥110 mg/dl* | 1) ≥100 mg/dl* | 1) ≥100 mg/dl* |
Triglycerides | 2) ≥150 mg/dl | 2) ≥150 mg/dl* | 2) >150 mg/dl* |
HDL cholesterol | 3) <39 mg/dl | 3) <50 mg/dl* | 3) <50 mg/dl* |
Obesity | 4) BMI >30 kg/m2 or waist-to-hip ratio >0.85 | 4) Waist circumference ≥88 cm | 4) Waist circumference ≥80 cm† |
Blood pressure | 5) SBP ≥140 mmHg and/or DBP ≥90 mmHg* | 5) SBP ≥130 mmHg and/or DBP ≥85 mmHg* | 5) SBP ≥130 mmHg and/or DBP ≥85 mmHg* |
Fulfillment of the cutoff score if alternatively taking medication for diabetes, dyslipidemia, or hypertension; microalbuminuria was not available when defining the metabolic syndrome via the WHO clinical criteria.
Citerion was ethnic specific; sample was primarily non-Hispanic Caucasian. DBP, diastolic blood pressure; SBP, systolic blood pressure.